✦ LIBER ✦

Mesangial Cell Proliferation Inhibitors for the Treatment of Proliferative Glomerular Disease

✍ Scribed by Yasuhisa Kurogi

Publisher: John Wiley and Sons
Year: 2003
Weight: 51 KB
Volume: 34
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200313229

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

For Abstract see ChemInform Abstract in Full Text.

📜 SIMILAR VOLUMES

ChemInform Abstract: Inhibitors of Trypt

ChemInform Abstract: Inhibitors of Tryptase for the Treatment of Mast Cell-Mediated Diseases

✍ K. D. RICE; R. D. TANAKA; B. A. KATZ; R. P. NUMEROF; W. R. MOORE 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 24 KB 👁 2 views

γ-secretase inhibitors for the treatment

γ-secretase inhibitors for the treatment of Alzheimer's disease

✍ Wen-Lian Wu; Lili Zhang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

B cell–ablative therapy for the treatmen

B cell–ablative therapy for the treatment of autoimmune diseases

✍ Dhavalkumar D. Patel 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 31 KB 👁 2 views

Pluripotent human stem cells for the tre

Pluripotent human stem cells for the treatment of retinal disease

✍ Teisha J. Rowland; David E. Buchholz; Dennis O. Clegg 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

## Abstract Despite advancements made in our understanding of ocular biology, therapeutic options for many debilitating retinal diseases remain limited. Stem cell‐based therapies are a potential avenue for treatment of retinal disease, and this mini‐review will focus on current research in this are

Dendritic cells in tolerance induction f

Dendritic cells in tolerance induction for the treatment of autoimmune diseases

✍ Maria Rescigno 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

## Abstract Autoimmune diseases are characterized by the loss of tolerance toward self‐antigens and the induction of destructive immune responses leading to tissue damage. Most patients with autoimmune diseases are treated with immunosuppressive drugs that suppress the immune response in a non‐spec

Toward the discovery of small molecule P

Toward the discovery of small molecule PTP1B inhibitors for the treatment of metabolic diseases

✍ Andrew J. Nichols; Robert D. Mashal; Bork Balkan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 1 views

## Abstract PTP1B is a protein tyrosine phosphatase involved in insulin and leptin signaling and is a primary mechanism for down‐regulating both the insulin and leptin receptor signaling pathways. Animals deficient in PTP1B have improved glucose regulation and lipid profiles and are resistant to we